Ocugen (OCGN) Interest Expenses (2014 - 2026)
Ocugen (OCGN) posted Interest Expenses of $18.1 million for Q1 2026, up 1260.36% on a QoQ basis from $1.3 million in Q4 2025, and up 1341.53% year-over-year from $1.3 million in Q1 2025.
Ocugen (OCGN) Interest Expenses (2014 - 2026) Analysis & Trends
Ocugen's Interest Expenses history runs 13 years deep, the most recent figure standing at $18.1 million for Q1 2026.
- Quarterly Interest Expenses rose 1341.53% year-over-year to $18.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.1 million (up 850.18% YoY) and the FY2025 annual result came in at $136.0 million, up 13.73% from the prior year.
- Interest Expenses was $18.1 million for Q1 2026 at Ocugen, up from $1.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $112.4 million in Q4 2023 and bottomed at $29000.0 in Q3 2024.
- A 5-year average of $16.9 million and a median of $5.2 million in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses surged 478520.0% — and 2024, when it slumped 99.47%.
- Ocugen's Interest Expenses stood at $95.7 million in 2022, then increased by 17.43% to $112.4 million in 2023, then slumped by 99.47% to $601000.0 in 2024, then jumped by 121.63% to $1.3 million in 2025, then surged by 1260.36% to $18.1 million in 2026.
- Business Quant data shows OCGN's Interest Expenses at $18.1 million in Q1 2026, $1.3 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - | 18.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.12 Mn |
| Mar 31, 2026 | 18.12 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 6.35 Mn |
| Jun 30, 2025 | 6.35 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 601,000.00 |
| Dec 31, 2024 | 601,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 5.54 Mn |
| Jun 30, 2024 | 5.54 Mn |
| Mar 31, 2024 | 6.19 Mn |
| Mar 31, 2024 | 6.19 Mn |
| Dec 31, 2023 | 112.41 Mn |
| Dec 31, 2023 | 112.41 Mn |